ARSD, arylsulfatase D, 414

N. diseases: 163; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.060 Biomarker phenotype BEFREE Our findings emphasise the need to provide timely assessment and treatment of anxiety and depression in ASD. 31190198 2019
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.060 GeneticVariation phenotype BEFREE There was no significant difference in risks for ADHD (OR = 1.563; 95% CI, 1.382-1.769); sleep disorders (OR = 2.100; 95% CI, 1.322-3.336); anxiety (OR = 1.339; 95% CI, 1.062-1.687); depression (OR = 1.402 95% CI, 1.256-1.565); conduct disorder (OR = 1.494 95% CI, 1.230-1.815); or ASD (OR = 2.574; 95% CI, 1.469-4.510; <i>Q</i><sub>b</sub> = 8.344, <i>p</i> = 0.138). 31447731 2019
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.060 Biomarker phenotype BEFREE Maternal anxiety or depression was associated with 2.7 times the odds (95% confidence interval: 1.4, 5.3) of Type 4 or Dysregulated ASD in the child; maternal anxiety and depression was associated with 4.4 times the odds (95% confidence interval: 1.4, 14.0) of Type 4 or Dysregulated ASD in the child. 30128718 2019
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.060 GeneticVariation phenotype BEFREE Findings help pinpoint susceptibilities in ASD that may confer increased risk for depression. 29882107 2018
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.060 Biomarker phenotype BEFREE Encouragingly, our findings suggest that HADS provides a reliable and valid assessment of anxiety and depression in ASD. 28922575 2018
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.060 Biomarker phenotype BEFREE Current ASD traits were correlated with emotional disorders and with need for treatment augmentation (psychiatric inpatient or day patient admission), but this relationship was not significant after the contribution of depression had been controlled for. 28058799 2017